Ovine placentomes vary in shape, with type A placentomes being concave, type D convex, and types B and C intermediate in morphology. It has been speculated that as placentomes advance in type they differ in vascularity and nutrient transport capacity. Our objective was to determine cellularity and vascularity measurements, angiogenic factor expression, and arterial vasoactivity within different morphologic types of placentomes. On Day 130 of gestation, placentomes were collected from multiparous ewes (n ¼ 38) and were evaluated for size, cellularity estimates, angiogenic factor mRNA expression, capillary vascularity (capillary size, capillary surface density [CSD], capillary number density [CND], and capillary area density [CAD]), and vasoreactivity to potassium chloride and angiotensin II. The average weight and size of type A and B placentomes were less (P , 0.01) than those of type C and D placentomes. Placentome morphology did not affect (P ! 0.24) cotyledonary or caruncular cellularity estimates or percentage of cellular proliferation. Placentome morphology affected (P ! 0.41) neither caruncular CAD, CND, CSD, or capillary size nor cotyledonary CND, CSD, or capillary size. Cotyledonary CAD was increased (P , 0.01) in type B and D placentomes compared with type A placentomes. Furthermore, placentome type did not affect (P ! 0.06) angiogenic factor gene expression in the cotyledon or the caruncle. Size, but not morphologic type of placentome, was associated with greater caruncular artery contractility to potassium chloride and angiotensin II (P , 0.01 for both). Placentome size, but not morphologic type, may be important for vascularity and nutrient transfer in the placenta of the pregnant ewe.
INTRODUCTION
The placentome consists of interdigitated fetal cotyledonary and maternal caruncular microvilli and is the site of maternalfetal nutrient exchange in ruminant animals. Proper establishment of the vascularity of the placentome is essential for the maternal system to support the exponentially growing fetus in the last trimester of pregnancy [1, 2] . Furthermore, there is a close relationship between fetal weight, placental size, and uterine and umbilical blood flows [1, 3] . Placental size may be indicative of fetal growth, as placental restriction has been shown to decrease fetal size [3] .
Vatnick et al. [4] first described a morphologic classification system for placentomes in which the placentomes are classified based on their shape. Type A placentomes consist of maternal tissue surrounding a small portion of fetal tissue, type B and C placentomes are intermediate in shape, and type D placentomes consist of fetal tissue completely surrounding maternal tissue [4, 5] . Vonnahme et al. [5] reported that maternal undernutrition from Days 28 to 78 resulted in decreased fetal weight unless undernourished dams increased the proportions of type C and type D placentomes in the uterus. Therefore, it was hypothesized that type C and D placentomes may be more functional, and perhaps more vascular, than type A and B placentomes [5] . To our knowledge, there are no data that describe the vascularity or nutrient transfer capacity of the various morphologic types of ovine placentomes. The objective of the present study was to differentiate between structural and vascular differences in placentomes based on morphologic types in the ewe.
MATERIALS AND METHODS
This project was approved by the North Dakota State University Animal Care and Use Committee. Western whiteface ewes were bred to an intact ram, and all pregnant ewes (n ¼ 38) were housed indoors in group pens. Ewes were fed alfalfa hay ad libitum once daily and had unlimited access to water.
Tissue Collection
Ewes were slaughtered on mean 6 SEM Day 130 6 5 of gestation. Before slaughter, ewes were weighed. Gravid uteri were removed from the body cavity, and their weights were recorded. The uterus was opened along the antimesometrial border, and the umbilical cord was tied with string. The fetuses were then removed, and individual fetal weight was recorded.
Placentome Morphologic Classification and Measurements
For all ewes, individual placentomes were classified morphologically based on the classification system first described by Vatnick et al. [4] . This system classifies placentomes based on their shapes. Type A placentomes are concave in shape, with the maternal tissue completely surrounding the fetal tissue. Type B placentomes consist of fetal tissue beginning to grow over the surrounding maternal tissue. Type C placentomes are flat and consist of a larger portion of fetal tissue that has begun to surround the maternal tissue. Type D placentomes contain mostly fetal tissue, which surrounds the maternal tissue. When determining the morphology, there were several intermediate types of placentomes found within the placenta; intermediate types were in between the more definitive types (e.g., type B to type C). If the placentomes were intermediate types, they were considered to be the more advanced type (e.g., type B to type C was classified as type C) and were not used for cellularity, histological, angiogenic factor, or vasoactivity analyses (described herein). After the morphologic classification was assigned, placentomes were individually weighed. Furthermore, placentome diameters were measured by placing the placentomes on a flat surface, determining the length and width (in centimeters), and averaging the measurements. Therefore, for all ewes, total and average placentome weight and average diameter were determined. Furthermore, within each placentome type, total and average weight and average diameter were calculated. To determine the contribution of each placentome type, the total placentome weight and the percentage of total placentome weight for each type were also calculated. In a subset of ewes (n ¼ 15), four to 10 placentomes of each morphologic type were separated into caruncular and cotyledonary components and were individually weighed so that the caruncular:cotyledonary weight ratio per type could be determined.
Determination of Dry Weight, Cellularity, and Angiogenic Factor Expression
In a subset of ewes (n ¼ 15), cotyledonary and caruncular tissues from all placentome types were separated, and their weights were recorded. Approximately 5 g of cotyledonary and caruncular tissues from each placentome type was snap frozen in isopentane in liquid nitrogen and stored at À808C until further analysis.
To determine the dry weight percentage, cotyledonary and caruncular tissues (1 g) from each placentome type were then placed into a Genesis 25LE drying oven (VirTis, Gardiner, NY) for 24-48 h until the tissues were dry. Tissues were removed from the oven, and dry weight was measured and recorded.
Analyses for the effect of placentome morphology on protein, DNA, and RNA were conducted for cotyledonary and caruncular tissues from each placentome type within a uterus using the diphenylamine procedure, orcinol procedure, and Bradford protein assay, respectively [6, 7] . Furthermore, ratios of RNA:DNA (measurement of cell activity, or protein synthetic potential) and protein:DNA (measurement of cell size) were calculated.
Quantification of Angiogenic Factors
Several angiogenic factors that have been shown to affect placental angiogenesis were analyzed using quantitative real-time PCR. these include the following: vascular endothelial growth factor (VEGF), VEGF receptors (FLT1 and KDR), placental growth factor (PGF), endothelial nitric oxide synthase (NOS3), soluble guanylate cyclase (NO receptor, GUCY1B3), basic fibroblastic growth factor (FGF2), FGF receptor (FGFR), angiopoietin I and II (ANGPT1 and ANGPT2), and ANGPT receptor (TEK) ( Table 1) . Total RNA was extracted using Tri-Reagent (Molecular Research Center, Cincinnati, OH). Total RNA concentration was determined by capillary electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Technologies, Wilmington, DE) and total RNA was used for RT-PCR analysis to determine mRNA levels for VEGF, FLT1, KDR, PGF, NOS3, GUCY1B3, FGF2, FGFR, ANGPT1, ANGPT2, and TEK by methods previously validated in our laboratories [8] [9] [10] [11] , with the following modifications: A multiplex reaction was performed. Into each well of the plate, 18S mRNA was added to each well to serve as an internal control to minimize sample variation. Expression of each angiogenic factor gene of interest was normalized to expression of 18S in a multiplex reaction using the human 18S predeveloped assay reagent (PDAR; Applied Biosystems, Foster City, CA). The PDAR solution, which is primer limited and contains a VIClabeled probe, was further adjusted by using one-fourth the recommended amount so that it would not interfere with amplification of the FAM-labeled probes of angiogenic genes of interest. Furthermore, standard curves were generated with the multiplex reaction mix using increasing concentrations of an ovine placentome cDNA pool. Ratios of the gene of interest with respect to the 18S gene expression levels in each individual reaction tube were used for quantifying the gene expression. Because of few type D placentomes (n ¼ 3) processed for RT-PCR analyses, comparisons were made between types A and B vs. types C and D.
Vasoactivity Assays
On collection of the uterus, a portion of the tract containing multiple morphologic types, always located at the base of the gravid uterine horn, was selected for placentome perfusion (n ¼ 6 ewes) and analysis of vasoactivity. Single placentomes were selected for comparisons between varying types (A or B vs. C or D; n ¼ 3 ewes) or varying sizes (small vs. large; n ¼ 3 ewes) within a type when the placenta consisted of only one type of placentome (i.e., large A vs. small A or large C vs. small C). Placentomes, still attached to the uterine wall, were dissected from the gravid uterus and were placed in oxygenated Krebs bicarbonate buffer (Krebs; 11.5 mM dextrose, 1.2 mM monopotassium phosphate, 4.7 mM potassium chloride, 2.5 mM calcium chloride dihydrate, 1.2 mM magnesium sulfate heptahydrate, 112.9 mM sodium chloride, and 25.0 mM sodium bicarbonate).
After returning to the laboratory, two placentomes were selected for immediate perfusion. The remaining placental tissues were placed into a container filled with Krebs, which was gassed continuously and placed in an ice-water bath for later use. Each selected placentome was then individually placed in a plexiglass perfusion chamber (11.5 cm in diameter) submerged in Krebs. An individual caruncular artery was cannulated with one branch of a four-way catheter. Cotyledonary arteries were also cannulated; however, the responses to potassium chloride and angiotensin II were low or not observed; therefore, only maternal vascular responses will be reported. The catheter was flushed with Krebs until the venous outflow was clear of blood. The chamber was then sealed and connected to tubing, allowing a continuous supply of warmed Krebs. Krebs was warmed to 398C as it passed through a Pyrex coiled reflux condenser (Fisher, Pittsburgh, PA; Lauda Water Circulator, LaudaKönigshofen, Germany) flowing through the chamber at a rate of 30-50 ml/ min. One branch of the catheter was supplied with warmed Krebs via a pump with a simulated heart pulse similar to that of a late pregnant ewe (85 beats/ min), which was achieved via a pulsatile blood pump (1407 PBP; Harvard Apparatus, Holliston, MA). Another branch of the catheter was attached to a syringe infusion pump (Pump 22; Harvard Apparatus) through which Krebs was infused at a rate of 0.5 ml/min, and that was used to administer drug doses into the vascular bed. The last branch of the catheter was attached to a Transbridge TBM4M pressure transducer (World Precision Instruments, Sarasota, FL), and pressures were measured (in millimeters of mercury) and were recorded using the WinDaq software program (DI-710 Series, Dataq Institute Inc., Akron, OH).
Once the placentome was connected, equilibration time was approximately 45 min. Before the perfusion protocol began, 175 mM potassium chloride was administered as a bolus, and the change in perfusion pressure was evaluated. Next, sequential bolus doses of 0. 25 M) were injected into the infusion line every 5 min. At the end of the perfusion protocol, the placentome was again challenged with a bolus of 175 mM potassium chloride to ensure that the vascular bed was still responsive. After the last injection was given, the placentome was allowed to return to baseline before cessation of the procedure. Contractile responses were indicated by increases in arterial pressure. Immediately before administering each dose, flow was recorded using a flowmeter (Gilmont Instruments, Inc., Barrington, IL) attached immediately downstream from the pulsatile blood pump.
Uterine Fixation Procedures
Ewes (n ¼ 23) were randomly assigned to have their uteroplacental tissues fixed with Carnoy fixative for cell proliferation and tissue vascularity studies. One hour before slaughter, ewes were injected with a single bolus dose (0.23 ml/kg of body weight) of 5-bromo-2-deoxy-uridine (BrdU; Sigma-Aldrich, St. Louis, MO). On removal of the fetus, the uterus was fixed by perfusion with Carnoy fixative (60% ethanol:30% chloroform:10% glacial acetic acid) using methods previously described in our laboratory [11] , with the following modifications: The entire uterus was first perfused with PBS until the venous outflow was clear. The uterine artery was then perfused with Carnoy fixative. Unpublished observations (Borowicz and Reynolds) from previous investigation in the ewe in our laboratory showed that fetal placental capillaries will remain open when the maternal placental vascular bed is perfused. After perfusion, placentomes were removed from the uterus. Morphologic type was assessed [4, 5] , and placentome diameters and weights were determined as already described. Placentomes were then sliced (0.5-cm thick) using a StadieRiggs knife (Thomas Scientific, Swedesboro, NJ). Thereafter, the placentome slices were immersion fixed in Carnoy solution for an additional 24 h to ensure 
Cellular Proliferation Measurements in Fixed Placentomes
After fixation in Carnoy solution, the placentomal tissue slices were dehydrated in a graded series of ethanol and, finally, in clearing agent (HistoClear; National Diagnostics, Atlanta, GA). The dehydrated tissue slices were then embedded in paraffin wax. Embedded tissues were sectioned at 5 lm and were stained for evaluation of cell proliferation using a mouse anti-BrdU primary antibody (Roche Molecular Biochemicals, Indianapolis, IN), which was detected using a biotinylated anti-mouse secondary antibody and the avidin-biotin-peroxidase system, consisting of avidin and a biotinylated horseradish peroxidase macromolecular complex (mouse IgG serum kit; Vector Laboratories Inc., Burlingame, CA). Tissues were further stained for periodic-acid Schiff reagent and were counterstained with hematoxylin. Photomicrographs were taken using the 403 objective of a Nikon Eclipse E800 Confocal Microscope (Nikon Instruments Inc., Melville, NY). Fifteen micrographs were randomly taken throughout a slide, represented at least three types of placentomes from each ewe, and were analyzed for proliferating cells using the Image-Pro Plus software package (Image-Pro Plus version 5.0, Media Cybernetics, Houston, TX) as previously described [12] .
Vascularity Measurements and Image Analysis
For analysis of cell proliferation, 15 images were taken randomly from each placentome type for ewes that had three or more placentome types. For cotyledonary measurements, six photomicrographs were taken for each image at intervals of 1 lm using the 6003 objective on the Nikon Eclipse E800 Confocal Microscope (Nikon Instruments Inc.) and subsequently were stacked using the three-dimensional algorithm of the Metamorph Imaging program (Universal Imaging Corporation, Downington, PA). Caruncular images were taken at 4003 magnification using the Nikon Eclipse E800 Confocal Microscope (Nikon Instruments Inc.). Vascularity measurements were performed for cotyledonary and caruncular tissues using the Image-Pro Plus version 5.0 software package (Media Cybernetics). Vascularity measurements were similar to those described by Borowicz et al. [11] . The parameters determined for placentome vascularity were capillary size (average crosssectional area per capillary), capillary area density (CAD [total capillary area per unit of tissue area]), capillary number density (CND [number of capillaries per unit tissue area]), and capillary surface density (CSD [capillary circumference per unit of tissue area]).
Statistical Analysis
Statistical analysis was performed using the general linear models procedure of SAS (SAS Institute Inc., Cary, NC) for the effects of fetal number, placentome morphologic type, tissue type, and their interactions. P , 0.05 was considered statistically significant. Data are presented as mean 6 SEM. For vasoactivity, the percentage change in perfusion pressure from baseline at the initial dose was determined for each subsequent dose. Data for vascular perfusion were evaluated using the general linear models procedure of SAS (SAS Institute Inc.); the model statement included placentome morphology. Ewe was used as a covariate to remove variation based on individual ewe.
RESULTS
Ewes were characterized based on the number of fetuses present at the time of slaughter (Table 2) . Of 38 ewes, 16 ewes had singletons, 16 ewes had twins, and 6 ewes had triplets. Number of fetuses did not affect ewe weight on Day 130 of pregnancy (P ¼ 0.52). Gravid uterine weight increased (P , 0.01) with more fetuses. Similarly, total fetal weight was greatest (P , 0.01) in triplet and twin pregnancies compared with singleton pregnancy. Although placentome numbers increased with more fetuses, the morphologic composition (i.e., the percentages of type A, B, C, and D placentomes) did not differ (P ! 0.46). Average and total placentome weights, as well as total fetal membrane weights, were increased (P , 0.01) in twin and triplet pregnancies compared with singleton pregnancy. Although there was no effect (P ¼ 0.35) of fetal number on total caruncular weight, cotyledonary weight was increased (P , 0.01) in twin and triplet pregnancies compared with singleton pregnancy. There was no effect (P ¼ 0.25) of fetal number on fetal:placentomal mass ratio.
For placentome weight and diameter, there was no interaction (P ! 0.41) between placentome morphology and number of fetuses, so the main effects of placentome morphology are given in Table 3 . The greatest (P , 0.01) number and percentage of placentomes in the gravid uterus were type A, followed by type B, and then types C and D. Although there was an overlap in the range of weights and diameters among all morphologic types of placentomes, the average weight and diameter of type A and B placentomes were less than (P , 0.01) those of type C placentomes, which were lighter and smaller than type D placentomes. However, calculating the total weight and the percentage of the total weight of placentomes, type A placentomes comprised the greatest (P , 0.01) proportion of placentome weight within the uterus, followed by type B, and then by types C and D, which 978 did not differ in total weight. The caruncular:cotyledonary mass ratio was similar between type A and B placentomes, which had a decreased (P , 0.01) proportion of cotyledonary tissue compared with type C and D placentomes.
There was no effect (P ! 0.24) of placentome morphology on dry matter or cellularity estimates (Table 4) ; however, cotyledonary tissue had increased (P 0.02) protein, RNA, and DNA concentrations compared with caruncular tissue. Furthermore, the percentage of proliferating cells in cotyledonary tissue was greater than (P , 0.01) that in caruncular tissue.
When angiogenic factor mRNA expression was determined for type A and B placentomes and for type C and D placentomes, no differences were observed based on placentome type within caruncular or cotyledonary tissue (Table 5) . However, there was a tendency (P ¼ 0.06) for type C and D placentomes to have greater cotyledonary GUCY1B3 mRNA levels compared with type A and B placentomes.
In the caruncular portion of the placentome, capillary vascularity measurements, including capillary size, CSD, CAD, and CND, did not differ (P ! 0.31) based on placentome morphologic type (Fig. 1) . Although there also was no effect (P ! 0.57) of placentome morphology on capillary size, CSD, or CND in the cotyledon, cotyledonary CAD was greater (P , 0.01) for type B and D placentomes compared with type A placentomes, with type C being intermediate (Fig. 2) .
Responsiveness of the caruncular vascular bed to potassium chloride and angiotensin II was greater (P , 0.01) in larger compared with smaller placentomes, independent of the morphologic type (Figs. 3 and 4 and Table 6 ). When the placentomes were run pairwise based on morphologic type and size (e.g., a small A placentome vs. a large A placentome), there was greater variation in their responsiveness to potassium chloride or angiotensin II compared with placentomes analyzed based solely on morphology (Table 6 ).
DISCUSSION
Our results suggest that placentome morphology, or size, has little effect on capillary vascularity or expression of angiogenic factors in the ewe. Cellularity (DNA, RNA, and protein) and the rate of cell proliferation also did not differ among the various placentome morphologies. However, vascular function was affected by placentome size but was still not affected by morphology. We report, as have others [4, 5] , that type A placentomes are on average smaller and lighter than the other morphologic types.
Our data demonstrate that most of the placenta consists of type A placentomes compared with all other morphologic types (i.e., types B, C, and D). These data are similar to results for control ewes in studies by Vatnick et al. [4] , Clarke et al. [13] , Steyn et al. [14] , Gardner et al. [15] , and Osgerby et al. [16] , as well as for ewes in which the fetal or placental weights were compromised [5, [13] [14] [15] [16] [17] [18] [19] [20] [21] .
It has been hypothesized that stressors such as nutrient restriction or increased numbers of fetuses in the uterus may ''drive'' the morphologic conversion of placentomes from a ''less advanced'' type (i.e., type A or B) to a ''more advanced'' [5, 13, 14, 16, 18, 19] , hypoxia [17] , or fetectomy [4] , a shift occurs in placentomes from type A to more advanced types such as C and D. In these studies, it was suggested that the shift to more advanced types of placentomes was an attempt to rescue the fetus, perhaps because of increased placentome vascularity or blood flow. For example, Vatnick et al. [4] reported that when fetectomy was performed on twins there was an increase in the number of more advanced types of placentomes, with fetuses being similar in weight to singletons. These authors suggested that the conversion to more advanced types may ''rescue'' the fetus by supplying increased nutrients. However, Gardner et al. [15] showed that short-term umbilical cord compression did not increase the incidence of type C or D placentomes. Moreover, Ward et al. [20] demonstrated that treatment with cortisol may result in reversion of placentomes from more advanced types to less advanced types. In addition, reversion of placentomes occurs during the prepartum period, when fetal cortisol levels are rising most rapidly [20] . In our laboratory, we observed uteri consisting of only type A placentomes in singleton, twin, and triplet pregnancies during this study. Therefore, it does not seem that morphology alone will predict nutrient delivery or fetal outcome. Means 6 SEM within a measure differ (P , 0.01).
980
There were no differences in cellular proliferation, DNA, RNA, protein, or the ratios of RNA:DNA (potential cellular activity) or protein:DNA (potential hypertrophy) based on placentome type in caruncular or cotyledonary tissue. Vatnick et al. [4] demonstrated that there was no difference in DNA content between control and fetectomized ewes. However, nutritional stressors such as overnutrition from conception to late pregnancy have been shown to decrease placentome DNA, RNA, and protein concentrations [22] . Based on the present study, these effects do not seem to be associated with placentome morphology.
In this study, there were no caruncular vascularity differences and one difference in cotyledonary vascularity (CAD) due to placentome morphology. Borowicz et al. [11] found that from mid to late gestation, caruncular CAD increases 3-fold, CND increases 1.5-fold, CSD increases 2-fold, and capillary size increases 2-fold, whereas cotyledonary CAD increases 6-fold, CND increases 12-fold, CSD increases 6-fold, and capillary size decreases 2-fold. Although caruncular vascularity measurements were unaffected by morphologic type, cotyledonary CAD was increased 0.13-fold in type B and D placentomes compared with type A placentomes. An increase in CAD may allow for increased blood flow to the fetal portion of the placentome; however, with this slight increase in CAD-and the fact that it was not observed in all advanced morphologic types of placentomes-there may be no physiological advantage to the slight change in CAD due to morphologic type.
Consistent with the lack of changes in the vascularity of the placentomes, caruncular and cotyledonary angiogenic factor expression was unaffected by morphologic type of placentome. However, there was a tendency for more advanced placentomes to have greater cotyledonary GUCY1B3 mRNA levels. In a recent study by Galan et al. [23] , the concentration of NOS3 protein was 14-fold greater in cotyledonary tissue compared with caruncular tissue on Day 90 of gestation. In our study, there was no difference between tissues in NOS3 expression on Day 130 of gestation; however, protein expression was not determined. Moreover, Borowicz et al. [11] also determined that at Day 130 of gestation there is no difference between caruncular and cotyledonary expression of NOS3 or GUCY1B3. There also was no effect of placentome type on expression of VEGF or its receptors (FLT1 or KDR). In contrast, Jensen et al. [21] reported an increase in VEGF mRNA levels in type B placentome compared with all other types.
Because VEGF is a major regulator of the angiogenic process, one could assume that on Day 130 of gestation, when rapid fetal growth is occurring, there would be an increase in blood vessel formation to allow for an increase in blood flow and ultimately in nutrients reaching the fetus; however, blood flow was not measured in this study. Placental growth factor expression was increased in cotyledonary tissue compared with Regnault et al. [24] , indicating that angiogenesis may be occurring in cotyledonary tissue but not in caruncular tissue. The angiopoietins are another major family of factors that affect angiogenesis and work in concert with the VEGF family. In the present study, there was no difference in expression of these factors based on placentome morphologic type, indicating that the angiogenic process is unaffected by placentome morphology. These data are supported by Jensen and coworkers [25] , who found that placentome morphology did not alter blood flow per gram of tissue when microspheres were used to determine blood flow to cotyledonary tissue in late pregnant ewes. Although angiogenic factors and capillary density were similar regardless of placentome morphology, vascular function was affected by placentome size but not by morphology. Arterial responses for potassium chloride and angiotensin II were not increased in large compared with small placentomes. Vonnahme et al. [26] demonstrated a 2-fold to 4-fold increase in responsiveness to a depolarizing dose of potassium chloride in nutrient-restricted pregnant cows compared with those that were not nutrient restricted. Although there was no nutritional treatment in the present study, larger placentomes were more sensitive to potassium chloride. Similarly, larger placentomes were more responsive to angiotensin II. A study performed by Cox et al. [27] demonstrated that uterine vasculature is highly sensitive to angiotensin II in sheep. Adequate blood flow to the placenta is necessary for fetal growth [28] ; therefore, it is necessary to determine placentome responsiveness to various vasoconstricting and vasodilating drugs. In future studies of vasoactivity, placentomes of similar size should be compared.
In conclusion, our study demonstrated that placentome morphology does not affect placental vascularity, expression of angiogenic factors, cell proliferation, or tissue composition. However, large placentomes were shown to have an increased responsiveness to vasoconstricting drugs. Overall, it seems that placentome size, or total vascular bed size, may be more indicative of placentome vascularity and function. However, the role of placentome morphology on nutrient delivery has not been evaluated directly.
